Evidence map›Paper›PMID 39802824›Full record

ArticleVirus evolution2025

A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapy.

Aniqa Shahid, Bradley R Jones, Maggie C Duncan, Signe MacLennan, Michael J Dapp, Mark H Kuniholm, Bradley Aouizerat, Nancie M Archin, Stephen Gange, Igho Ofotokun and 6 more

Abstract read
In one paragraph

Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Aniqa ShahidFaculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC V5A 1S6, Canada.
Bradley R JonesDepartment of Mathematics, Simon Fraser University, 8888 University Drive, Burnaby, BC V5A 1S6, Canada.
Maggie C DuncanFaculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC V5A 1S6, Canada.
Signe MacLennanFaculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC V5A 1S6, Canada.
Michael J DappDepartment of Microbiology, University of Washington, School of Medicine, 1705 NE Pacific St., Seattle, WA 98195, United States.
Mark H KuniholmDepartment of Epidemiology and Biostatistics, University at Albany, State University of New York, 1 University Place, Rensselaer, NY 12144, United States.
Bradley AouizeratCollege of Dentistry, New York University, 345 E. 24th St., New York, NY 10010, United States.
Nancie M ArchinUNC HIV Cure Center, Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, 130 Mason Farm Rd., Chapel Hill, NC 27599, United States.
Stephen GangeDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD 21205, United States.
Igho OfotokunDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA 30322, United States.ORCID https://orcid.org/0000-0003-2735-1903
Margaret A FischlDivision of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, 1951 NW 7th Ave., Miami, FL 33136, United States.
Seble KassayeDivision of Infectious Diseases and Tropical Medicine, Georgetown University, 3800 Reservoir Road NW, Washington, DC 20007, United States.
Harris GoldsteinDepartments of Microbiology and Immunology and Pediatrics, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, United States.
Kathryn AnastosDepartment of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, United States.
Jeffrey B JoyBritish Columbia Centre for Excellence in HIV/AIDS, 1081 Burrard St., Vancouver, BC V6Z 1Y6, Canada.ORCID https://orcid.org/0000-0002-7013-1482
Zabrina L BrummeFaculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC V5A 1S6, Canada.ORCID https://orcid.org/0000-0002-8157-1037

Funding

REACH: Research Enterprise to Advance a Cure for HIVUM1AI164565 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Marina Caskey, R. Brad Jones · 2021 to 2026
$32.9M
NIAID NIH HHS UM1 AI164565
6 · The paper itself

Abstract

Hypermutated proviruses, which arise in a single Human Immunodeficiency Virus (HIV) replication cycle when host antiviral APOBEC3 proteins introduce extensive guanine to adenine mutations throughout the viral genome, persist in all people living with HIV receiving antiretroviral therapy (ART). However, hypermutated sequences are routinely excluded from phylogenetic trees because their extensive mutations complicate phylogenetic inference, and as a result, we know relatively little about their within-host evolutionary origins and dynamics. Using >1400 longitudinal single-genome-amplified HIV

Indexed as

evolutionHIVhypermutationpersistencephylogeneticsprovirusreservoir

Identifiers

PMID39802824
PMCPMC11724191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.